NCT01449344 Efficacy and Safety of R-HAD Alone or in Combination With Bortezomib in Patients With Relapsed or Refractory MCL Status UNKNOWN Phase PHASE3
NCT01442428 Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial Status WITHDRAWN Phase PHASE2/PHASE3
NCT01440582 Combination Therapy of Lenalidomide/Bortezomib/Dexamethasone and Panobinostat in Transplant Eligible New Diagnosed Multiple Myeloma (MM) Patients Status COMPLETED Phase PHASE1
NCT01434017 Comparison of Three Different Prophylactic Treatments of Postoperative Nausea and Vomiting (PONV) in Children Status COMPLETED Phase PHASE4
NCT01432600 Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide Status COMPLETED Phase PHASE1/PHASE2
NCT01428492 Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma Status COMPLETED Phase PHASE1
NCT01424982 Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01422733 Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction Status WITHDRAWN Phase EARLY_PHASE1
NCT01421810 Ovarian Contribution to Androgen Production in Adolescent Girls Status ACTIVE_NOT_RECRUITING Phase NA
NCT01421797 Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation Status ACTIVE_NOT_RECRUITING Phase NA
NCT01421186 A Phase 1/2a Study of Human Anti-CD 38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma Status COMPLETED Phase PHASE1/PHASE2
NCT01415882 Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib Status COMPLETED Phase PHASE2
NCT01415583 Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy Status COMPLETED Phase NA
NCT01412879 S1106 Rituximab With Combination Chemotherapy or Bendamustine Hydrochloride Followed by Consolidation Chemotherapy and Stem Cell Transplantation in Older Patients With Previously Untreated Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT01408082 Efficacy and Safety Study of a Steroid/Antibiotic Combination Eyedrop to Treat Non-Bacterial Blepharitis Status COMPLETED Phase PHASE3
NCT01405924 Fosaprepitant (MK-0517, EMEND® IV) In Salvage Treatment of Chemotherapy-Induced Vomiting (MK-0517-030) Status TERMINATED Phase PHASE2
NCT01403415 Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE1
NCT01402284 Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients Status COMPLETED Phase PHASE2